| |
| |
|
| Insider
Information: |
Nea Partners 14, L.p. |
| Relationship: |
10% Owner |
| City: |
Timonium |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
27,478,464 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$92,224,502 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
27,478,464 |
|
|
| Total
Value |
$92,224,502 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2015-02-04 |
1,888,474 |
2015-02-04 |
0 |
Premium* |
|
|
Champions Biotechnology Inc |
CSBR |
10% Owner |
2015-03-11 |
18,750,000 |
|
0 |
Premium* |
|
|
Mulesoft, Inc |
MULE |
10% Owner |
2017-03-22 |
0 |
|
0 |
Premium* |
|
|
Synlogic Inc |
SYBX |
10% Owner |
2018-01-26 |
4,228,940 |
2017-08-28 |
0 |
Premium* |
|
|
Enliven Therapeutics Ord Shs |
ELVN |
10% Owner |
2022-04-06 |
2,611,050 |
2022-04-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2022-04-06 |
4 |
S |
$1.10 |
$281,827 |
D/D |
(255,463) |
2,611,050 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2022-04-05 |
4 |
S |
$1.07 |
$469,429 |
D/D |
(439,088) |
2,866,513 |
0 |
- |
|
| SYBX |
Synlogic Inc |
10% Owner |
– – • |
2018-01-26 |
4 |
A |
$9.75 |
$3,997,500 |
D/D |
410,000 |
4,228,940 |
0 |
- |
|
| SYBX |
Synlogic Inc |
10% Owner |
– – • |
2017-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
3,394,439 |
3,818,940 |
0 |
- |
|
| MULE |
Mulesoft, Inc |
10% Owner |
– – • |
2017-03-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,679,970) |
0 |
0 |
- |
|
| MULE |
Mulesoft, Inc |
10% Owner |
– – • |
2017-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
12,359,190 |
12,679,970 |
0 |
- |
|
| MULE |
Mulesoft, Inc |
10% Owner |
– – • |
2017-03-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
320,780 |
|
- |
|
| CSBR |
Champions Biotechnology I... |
10% Owner |
– – • |
2015-03-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
18,750,000 |
|
- |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2015-02-04 |
4 |
B |
$10.00 |
$5,000,000 |
D/D |
500,000 |
1,888,474 |
2.45 |
- |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2015-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,388,474 |
1,388,474 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
